Key terms

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest LLY news

Yesterday 7:10am ET Analysts Are Bullish on These Healthcare Stocks: Amgen (AMGN), Eli Lilly & Co (LLY) May 16 2:19pm ET Viking seen ‘holding up’ against obesity competition as Roche presents data May 16 1:44pm ET Roche data falls short of Viking weight loss drug, says Truist May 16 12:40pm ET Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Arvinas Holding Company (ARVN) and Progyny (PGNY) May 16 9:10am ET Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Celcuity (CELC) and 89bio (ETNB) May 16 8:12am ET Eli Lilly, Totus enter multi-target research collaboration May 16 6:53am ET Eli Lilly announces QWINT-2, QWINT-4 meet primary endpoints May 15 10:09am ET Jefferies retail/healthcare analysts to hold an analyst/industry conference call May 15 8:07am ET Eli Lilly announces retirement of Chief Ethics and Compliance Officer Weems May 14 1:30pm ET New Analyst Adjustments Prove Little Help to Eli Lilly (NYSE:LLY) May 14 8:17am ET Eli Lilly price target raised to $840 from $770 at Argus May 13 3:51am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Eli Lilly & Co (LLY), TruBridge (TBRG) and Ligand Pharma (LGND) May 10 5:09pm ET Cipla Wants to Partner with Eli Lilly (NYSE:LLY) in India May 09 7:17am ET Rani Therapeutics price target raised to $14 from $7 at BTIG May 09 1:30am ET Wall Street Analysts Are Bullish on Top Healthcare Picks May 08 6:32am ET Drugmakers work to make treatments to maintain weight loss, WSJ reports May 06 4:37am ET Barclays Remains a Buy on Eli Lilly & Co (LLY) May 03 11:13am ET Amgen price target raised to $325 from $315 at BofA May 02 2:31am ET Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Eli Lilly & Co (LLY) May 01 10:04am ET Eli Lilly price target raised to $892 from $850 at Truist May 01 8:55am ET Eli Lilly price target raised to $1,001 from $900 at BMO Capital May 01 7:29am ET Eli Lilly price target raised to $885 from $815 at Cantor Fitzgerald May 01 7:15am ET Truist Financial Keeps Their Buy Rating on Eli Lilly & Co (LLY) May 01 6:51am ET Galderma Seizes Ozempic Face Opportunity May 01 6:50am ET Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Axonics Modulation Technologies (AXNX) and Eli Lilly & Co (LLY) May 01 6:42am ET Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Exelixis (EXEL) and Zynex (ZYXI) May 01 6:37am ET Eli Lilly price target raised to $875 from $825 at Wells Fargo May 01 6:14am ET Wall Street Analysts Are Bullish on Top Healthcare Picks May 01 5:12am ET Eli Lilly price target raised to $913 from $810 at Barclays Apr 30 10:13am ET FTC expands patent listing challenges for drugs Apr 30 9:59am ET LLY Earnings: Eli Lilly Gains on Strong Q1 Earnings Beat

No recent press releases are available for LLY

LLY Financials

1-year income & revenue

Key terms

LLY Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

LLY Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms